First Affirmative Financial Network »

Brainstorm Cell Therapeutics shares owned by First Affirmative Financial Network

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by First Affirmative Financial Network from 13F filings

Historical chart of First Affirmative Financial Network investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by First Affirmative Financial Network consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by First Affirmative Financial Network

Quarter filed Position value Share count Share price at filing
2024-03-31 $8.6k 15k 0.56
2023-12-31 $4.3k 16k 0.27

More positions owned by First Affirmative Financial Network

Vanguard Scottsdale Fds Inter Term Treas (VGIT)
Spdr Ser Tr Portfolio Sh Tsr (SPTS)
Ishares Tr Msci Kld400 Soc (DSI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Invesco Exch Traded Fd Tr Ii S&p Gbl Water (CGW)
Proshares Tr Sht 7-10 Yr Tr (TBX)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Ishares Tr Gl Clean Ene Etf (ICLN)
Pimco Etf Tr Enhancd Short (EMNT)
Meta Platforms Cl A (META)
Mastercard Incorporated Cl A (MA)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)

View all positions for First Affirmative Financial Network

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics